Supply Chain
Outsourcing, Fragmentation, and the New Supply Chain Resilience Challenge
Pharma's Almanac
PAO-06-26-PA-07Jun 12, 2026
Outsourcing
The Hidden Operational Costs of Multi-Vendor Outsourcing Models
Pharma's Almanac
PAO-06-26-PA-06Jun 11, 2026
Molecular Barcodes
Molecular Tags, DNA Barcodes, and the Future of Pharmaceutical Supply Chain Authentication
David Alvaro, Ph.D.
Pharma's Almanac
PAO-05-26-PA-19Jun 8, 2026
Peptide Production
Peptide Manufacturing Enters the Industrial Era
David Alvaro, Ph.D.
Pharma's Almanac
PAO-05-26-PA-17May 18, 2026
Tariffs
The Intersection of Pharmaceutical Tariffs, Outsourcing, and Investment: Balance is Key
Cynthia A. Challener, Ph.D.
Pharma's Almanac
PAO-04-26-PA-15Apr 15, 2026
Sterile Supply Chain
The Fragile Backbone of Sterile Manufacturing: Container Closures, Filtration, and Supply Chain Resilience
David Alvaro, Ph.D.
Pharma's Almanac
PAO-03-26-PA-12Mar 20, 2026
Distribution
Univar Solutions Selected as Ingredion Pharma Solutions Distributor in United States and Canada
Ingredients + Specialties from Univar Solutions
PR-02-26-07Feb 25, 2026
Clinical Supply
The Hidden Cost of Clinical Delays
Alexander Fetkovsky; Roman Hrynchuk
SanaClis
PAO-11-25-CL-01Nov 24, 2025
Threats
What do you see as the biggest threat to the CDMO industry in 2026 or beyond?
Pharma's Almanac
PAO-10-25-RT-03Nov 3, 2025
GLP-1
Bridging Boundaries in the GLP-1 Era: Pharma, Nutra, and Food Solutions
Aaron Lee; Jessica Zhang
Ingredients + Specialties from Univar Solutions
PAO-10-25-CL-01Oct 7, 2025
Reshoring
Enabling the Reshoring of Pharma Manufacturing with Integrated Continuous Manufacturing
Salvatore Mascia, Ph.D.; Bayan Takizawa
CONTINUUS Pharmaceuticals
PAO-08-25-CL-01Aug 8, 2025
Supply Chain
Future-Proofing a Volatile Supply Chain Through Modular Biomanufacturing
Rasmus Pedersen, Ph.D.; John Stewart; Peter Skals
Fujifilm Biotechnologies
PAO-06-25-CL-03Jul 7, 2025
Supply Chain
Labviva Automates Chemical Supply Chain for the Life Sciences Industry
Labviva
PR-06-25-NI-10Jun 26, 2025
DSCSA
Understanding the Drug Supply Chain Security Act
Leandro Moreira
Frontier Scientific Solutions
PAO-04-25-CL-05May 8, 2025
Supply Chain
Building Resilient Pharma Supply Chains in an Uncertain World
Cynthia A. Challener, Ph.D.
Pharma's Almanac
PAO-25-30-26Mar 31, 2025
Supply Chain
What strategies are ensuring supply chain resilience in a post-COVID world?
Pharma's Almanac
PAO-02-25-RT-02Feb 26, 2025
Appointment
Frontier Scientific Solutions Appoints Kevin Nash as President of European Operations
Frontier Scientific Solutions
PR-02-25-NI-22Feb 25, 2025
Free Trade
Frontier Scientific Solutions’ Free Trade Zone Advantage Matters Amid Tariff Changes, Strengthening Life Sciences Supply Chain
Frontier Scientific Solutions
PR-02-25-NI-14Feb 19, 2025
Expansion
Bio X Cell Expands Global Reach with New Distribution Center in Beijing, China
Bio X Cell
PR-02-25-NI-05Feb 10, 2025
Product Stability
Reducing Tarmac Exposure to Enhance Biopharma Product Stability and Reduce Losses
Tony Yeates
Frontier Scientific Solutions
PAO-02-25-CL-03Feb 5, 2025